A substantially purified interleukin-1 inhibitor (IL-li which is active against interleukin-1 alpha or interleukin-1 beta or both of these substances. A recombinant-DNA method for the production of an interleukin-1 inhibitor (IL-li), and an isolated DNA sequence encoding a physiologically functional interleukin-1 inhibitor (IL-li). <IMAGE>
申请公布号
GR900300115(T1)
申请公布日期
1991.09.27
申请号
GR19900300115T
申请日期
1991.09.27
申请人
SYNERGEN, INC.
发明人
HANNUM, CHARLES H.;EISENBERG, STEPHEN P.;THOMPSON, ROBERT C.;AREND, WILLIAM P.;JOSLIN, FENNEKE G.;SOMMER, ANDREAS
